Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

Background: c-Kit/α-PDGFR targeted therapies are effective for gastrointestinal stromal tumors (GIST), but, >50% develop drug resistance. Methods: RTK expression (c-Kit, c-Met, AXL, HER-1, HER-2, IGF-1R) in pre-/post-imatinib (IM) GIST patient samples (n=16) and 4 GIST cell lines were examined fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahadevan, Daruka, Theiss, Noah, Morales, Carla, Stejskal, Amy E., Cooke, Laurence S., Zhu, Min, Kurtzman, Drew, Swart, Rachel, Ong, Evan, Qi, Wenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385828/
https://www.ncbi.nlm.nih.gov/pubmed/25557174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385828/
https://www.ncbi.nlm.nih.gov/pubmed/25557174

Ejemplares similares